Medical College of Wisconsin cancer researcher & key investigator on study of Pirtobrutinib, now FDA approved for patients previously treated for Mantle Cell Lymphoma
Results published in the Journal of Clinical Oncology highlight the drug’s impact and potential for B-cell lymphomas
2023-06-02
(Press-News.org) In a multicenter phase 1 and 2 trial (BRUIN, NCT03740529), researchers from leading cancer centers across the globe, including the Medical College of Wisconsin (MCW) in Milwaukee, tested Bruton tyrosine kinase inhibitor (BTKi), pirtobrutinib, in patients with pre-treated mantle cell lymphoma (MCL). Results of the study, which assessed the efficacy of the drug in a cohort of 90 patients with poor survival prognosis, demonstrated the reversible BTKi drug to be both safe and effective in achieving inhibition of defective B-cells. The results were published by the Journal of Clinical Oncology on May 16.
MCL is an aggressive, rare subtype of B-cell non-Hodgkin lymphoma. Patients with relapsed/refractory MCL have historically had a median survival rate of less than 10 months. Resistance or intolerance to covalent BTKi drugs is common. Pirtobrutinib is the first BTKi of any kind to demonstrate durable efficacy in patients with relapsed/ refractory MCL previously treated with a covalent BTKi therapy.
In the study of patients between 46 and 87 years of age, with a median of 3 prior lines of therapy, more than half (57.8%) responded to the drug with a median duration of response of 21.6 months.
“This trial builds on years of research to identify a safe and effective way to target b-cell signaling pathways and extend longevity for patients with MCL who have not responded to other forms of treatment,” said Nirav Shah, MD, associate professor of medicine at the Medical College of Wisconsin and the senior author on the study. “We now look forward to the results of future studies with pirtobrutinib, evaluating its role as a second line treatment option for patients with R/R MCL (NCT04662255, actively enrolling at the MCW Cancer Center).”
As the only academic medical center in southeast Wisconsin, and the largest cancer clinical trials program in the state, the MCW Cancer Center continues to offer a vast assortment of clinical trials and access to first-of-its-kind therapeutics for cancer patients in the region and beyond.
The study was sponsored by Loxo Oncology, Inc., a subsidiary of Eli Lilly and Company.
# # #
About the Medical College of Wisconsin
With a history dating back to 1893, The Medical College of Wisconsin is dedicated to leadership and excellence in education, patient care, research, and community engagement. More than 1,400 students are enrolled in MCW’s medical school and graduate school programs in Milwaukee, Green Bay, and Central Wisconsin in. MCW’s School of Pharmacy opened in 2017. A major national research center, MCW is the largest research institution in the Milwaukee metro area and second largest in Wisconsin. In the last 10 years, faculty received more than $1.5 billion in external support for research, teaching, training, and related purposes. This total includes highly competitive research and training awards from the National Institutes of Health (NIH). Annually, MCW faculty direct or collaborate on more than 3,100 research studies, including clinical trials. Additionally, more than 1,600 physicians provide care in virtually every specialty of medicine for more than 2.8 million patients annually.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-06-02
Beech leaf disease is an emerging threat to North American forest ecosystems. It was first discovered in northeastern Ohio in 2012, and has already spread to 12 additional U.S. states and Canadian provinces. At first the cause of the disease was unknown, and the sick and dying trees were diagnosed on symptoms alone: Dark banding along the leaf veins and shriveled, leathery leaves. But in 2017, nematodes were found in diseased leaves, and by 2020 we had the answer: A newly recognized subspecies of the wormlike creature, Litylenchus crenatae mccannii, was definitely associated with the symptoms.
In order to monitor the spread of the disease, to understand the nemotode’s ...
2023-06-01
(MEMPHIS, Tenn. – June 01, 2023) Infections and other diseases can cause red blood cells to rupture, releasing the oxygen-binding molecule hemoglobin, which breaks down into heme. Free heme can cause significant inflammation and organ damage, leading to morbidity and mortality. Researchers from St. Jude Children’s Research Hospital discovered NLRP12, an innate immune pattern recognition receptor, to be the key molecule responsible for inducing inflammatory cell death and pathology in response to heme combined with other cellular damage or infection. The finding provides a new potential drug target to prevent morbidity in certain illnesses. ...
2023-06-01
HOUSTON – (June 1, 2023) – An international team of marine biologists has discovered the remnants of ancient RNA viruses embedded in the DNA of symbiotic organisms living inside reef-building corals.
The RNA fragments are from viruses that infected the symbionts as long ago as 160 million years. The discovery is described in an open-access study published this week in the Nature journal Communications Biology, and it could help scientists understand how corals and their partners fight off viral infections today. But it was a surprising find because most RNA viruses are not known ...
2023-06-01
Davis, CA - The Necrotizing Enterocolitis (NEC) Society is thrilled to release the Neonatal Probiotics Toolkit. The Toolkit provides structure to clinicians in neonatal intensive care units (NICUs) as they consider the complex process and decision of whether to implement probiotics to help prevent NEC. The Toolkit is not a recommendation for or against the routine use of probiotics in the NICU, nor for or against the use of any product or preparation method.
NICUs and clinicians are encouraged to use the Toolkit to foster thoughtful, intentional dialogue and inclusive conversations amongst key stakeholders in the NICU, including the need for patient-families to understand ...
2023-06-01
Tumors are composed of rapidly multiplying cancer cells. Understanding which biochemical processes fuel their relentless growth can provide hints at therapeutic targets.
Researchers from Washington University in St. Louis have developed a technology to study tumor growth in another dimension — literally. The scientists established a new method to watch what nutrients are used at which rates spatially throughout a tissue.
By using this multidimensional imaging approach, they identified pathways whose activities are uniquely elevated in brain cancer, offering clues for potential treatment strategies. The study was published May 19 in Nature Communications.
“We ...
2023-06-01
COLUMBUS, Ohio – The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.
The three-year study found that a daily drop in each eye of a low dose of atropine, a drug used to dilate pupils, was better than a placebo at limiting eyeglass prescription changes and inhibiting elongation of the eye in nearsighted children aged 6 to 10.
That elongation leads to myopia, or nearsightedness, which starts in young kids and ...
2023-06-01
New Haven, Conn. — Yale University’s museums, libraries, and archives contain vast troves of cultural and scientific heritage that fire curiosity and fuel research worldwide. Now there’s a simple new way to make astonishing connections among millions of objects.
Starting today, anyone can explore the university’s unparalleled holdings online through LUX: Yale Collections Discovery — a groundbreaking discovery and research platform that provides single-point access to more than 17 million items, including defining specimens ...
2023-06-01
Microbial communities are especially active near hydrothermal seeps like those in the Guaymas Basin in the Gulf of California. The team of researchers has been working on understanding these communities for many years. Organic material deposited in the Guaymas Basin is cooked by heat sources from within the Earth, which breaks it down into crude oil and natural gas. Their components provide the primary source of energy for microorganisms in an otherwise hostile environment. In their latest study, the researchers have demonstrated that archaea use a previously unknown mechanism to degrade liquid petroleum ...
2023-06-01
– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments –
– Landmark research project is 100x larger than existing efforts –
– Data will be generated from thousands of patients across multiple cancers –
– University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universität Erlangen-Nürnberg , Charité ...
2023-06-01
CHAPEL HILL, N.C. – On July 1, North Carolina’s new abortion limits go into effect. As restrictions on abortions are being tightened across the United States, adolescents may encounter mounting obstacles that could prevent them from accessing abortion care.
Bianca A. Allison, MD MPH, an assistant professor in the Department of Pediatrics, sought to examine the awareness and knowledge that adolescents have about the legal landscape of abortion and how these changes might affect them and their communities.
The study, published in the Journal of Adolescent Health, found that many adolescents – across a diversity of ...
LAST 30 PRESS RELEASES:
[Press-News.org] Medical College of Wisconsin cancer researcher & key investigator on study of Pirtobrutinib, now FDA approved for patients previously treated for Mantle Cell Lymphoma
Results published in the Journal of Clinical Oncology highlight the drug’s impact and potential for B-cell lymphomas
